Caricamento...
The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review
An orphan disease is defined in the EU as a disorder affecting less than 1 in 2 000 individuals. The concept of ultra-orphan has been proposed for diseases with a prevalence of less than 1:50 000. Drugs for ultra-orphan diseases are amongst the most expensive medicines on a cost-per-patient basis. T...
Salvato in:
| Pubblicato in: | Orphanet J Rare Dis |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4520069/ https://ncbi.nlm.nih.gov/pubmed/26223689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-015-0305-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|